Reuters logo
BRIEF-Heat Biologics reports positive results from mid-stage lung cancer trial
March 21, 2017 / 11:25 AM / 8 months ago

BRIEF-Heat Biologics reports positive results from mid-stage lung cancer trial

March 21 (Reuters) - Heat Biologics Inc

* Heat Biologics reports positive interim phase 2 lung cancer results in patients treated with hs-110 in combination with a checkpoint inhibitor

* Immune responses to hs-110 were observed in all 5 patients that exhibited tumor reductions

* No tumor reductions were observed in patients that did not mount an immune response to hs-110 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below